The role of all-trans-retinoic acid (ATRA) treatment in newly-diagnosed acute promyelocytic leukemia patients aged >60 years

Avvisati, 1992, Acute promyelocytic leukemia, Br J Haematol, 81, 315, 10.1111/j.1365-2141.1992.tb08233.x Warrel, 1993, Acute promyelocytic leukemia, N Engl J Med, 329, 177, 10.1056/NEJM199307153290307 Awisati, 1991, Epidemiology of acute promyelocytic leukemia in Italy, Ann Oncol, 2, 405, 10.1093/oxfordjournals.annonc.a057974 Sanz, 1988, Acute promyelocytic leukemia. Therapy results and prognostic factors, Cancer, 61, 7, 10.1002/1097-0142(19880101)61:1<7::AID-CNCR2820610103>3.0.CO;2-6 Huang, 1988, Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia, Blood, 72, 567, 10.1182/blood.V72.2.567.567 Fenaux, 1993, Effect of all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial, Blood, 82, 3241, 10.1182/blood.V82.11.3241.3241 Awisati, 1996, AIDA (all-trans-retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a GIMEMA pilot study, Blood, 88, 1390, 10.1182/blood.V88.4.1390.bloodjournal8841390 Lo Coco, 1992, Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukemia, Lancet, 340, 1437, 10.1016/0140-6736(92)92625-P Kanamaru, 1995, All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia, Blood, 85, 1202, 10.1182/blood.V85.5.1202.bloodjournal8551202 Dombret, 1993, Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment, Leukemia, 7, 2